You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
1 September 2026 - Biopharmaceutical company AstraZeneca PLC (STO: AZN; LON: AZN; NYSE: AZN) said on Tuesday it has completed its exclusive global licence agreement with China-based Dizal Pharmaceutical Co., Ltd (SSE: 688192) for Zegfrovy (sunvozerti...
1 September 2026 - British-Swedish biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) and Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) on Tuesday announced European Commission approval for Enhertu (trastuzumab de...
31 August 2026 - US pharmaceutical company Eli Lilly and Company (NYSE: LLY) on Monday announced that it has agreed to acquire Merida Biosciences, Inc., a biotechnology business developing precision biologics for autoimmune and allergic diseases.The ...
31 August 2026 - Formosa Pharmaceuticals, Inc. (TWSE: 6838), a Taiwan-based biopharmaceutical company, announced on Friday that it has submitted a Clinical Trial Application (CTA) to European regulatory authorities to conduct a pivotal clinical trial...
31 August 2026 - Ascletis Pharma Inc. (Ascletis) (HKEX: 1672), a fully integrated biotechnology company, announced on Sunday that it has dosed its first participant in a global Phase III clinical programme of ASC30 for chronic weight management.ASC30...
28 August 2026 - Medical technology company GE HealthCare (Nasdaq:GEHC) on Friday unveiled three additions to its Vivid cardiovascular ultrasound portfolio: Vivid Explorer, Vivid Advanced and Vivid Focus, designed to address imaging and workflow need...
28 August 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) said on Friday that new analyses from the multinational MILOS study demonstrate the real-world impact of bempedoic acid, used alone or in combination with ezetimibe, in man...